MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis.
Barriga FM, Tsanov KM, Ho YJ, Sohail N, Zhang A, Baslan T, Wuest AN, Del Priore I, Meskauskaite B, Livshits G, Alonso-Curbelo D, Simon J, Chaves-Perez A, Bar-Sagi D, Iacobuzio-Donahue CA, Notta F, Chaligne R, Sharma R, Pe'er D, Lowe SW
Nat Cancer. 2022 Nov;3(11):1367-1385. doi: 10.1038/s43018-022-00443-5. Epub 2022 Nov 7.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
195282 | pFB2 | Bicistronic DTR and Puromycin resistance for positive/negative selection |
195283 | pFB2A | Bicistronic DTR and Hygromycin resistance for positive/negative selection |
195284 | pFB2B | Bicistronic HSV-TK and Puromycin resistance for positive/negative selection |
195285 | pFB2C | Bicistronic HSV-TK and Hygromycin resistance for positive/negative selection |
195286 | pFB2D | Bicistronic DTR-EGFP fusion and Puromycin resistance for positive/negative selection |
195288 | pFB2E | Bicistronic HSV-TK-EGFP fusion and Puromycin resistance for positive/negative selection |
195289 | pFB2F | Bicistronic HSV-TK and mScarlet resistance for positive/negative selection |
195290 | pFB2G | Bicistronic HSV-TK and mTagBFP resistance for positive/negative selection |